Gangrene primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Gangrene}}
{{Gangrene}}
{{CMG}}; {{AE}} [[User:Edzelco|Edzel Lorraine Co, D.M.D., M.D.]]
{{CMG}}; {{AE}} [[User:Edzelco|Edzel Lorraine Co, D.M.D., M.D.]]


==Overview==
==Overview==
Line 19: Line 18:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
[[Category:Needs content]]
[[Category:Needs english review]]
 
 
{{WH}}
 
{{WS}}

Revision as of 19:45, 12 April 2022

Gangrene Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gangrene from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gangrene primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gangrene primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gangrene primary prevention

CDC on Gangrene primary prevention

Gangrene primary prevention in the news

Blogs on Gangrene primary prevention

Directions to Hospitals Treating Gangrene

Risk calculators and risk factors for Gangrene primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Gas gangrene can be prevented by always monitoring the blood glucose levels and maintaining them within the normal range, and regular foot inspection, most especially in those patients with diabetes. Post-exposure prophylaxis may be needed by immunocompromised individuals if they were in close contact with patients with necrotizing infection due to Group A streptococcus. [1] Droplet and contact precautions are warranted to these susceptible individuals. [2]

Primary Prevention

References

  1. 1.0 1.1 Luzhnikov EA, Ananchenko VG, Bokarev IM, Akhtomova LV, Bochkarnikova OV (1976). "[Role of hemostasis in the development and prevention of pneumonia in patients with acute poisoning]". Sov Med (9): 146–8. PMID 0996606.
  2. 2.0 2.1 Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee (2007). "2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings". Am J Infect Control. 35 (10 Suppl 2): S65–164. doi:10.1016/j.ajic.2007.10.007. PMC 7119119 Check |pmc= value (help). PMID 18068815.